Vir Biotechnology (VIR) Prepaid Assets (2018 - 2026)
Vir Biotechnology (VIR) reported Prepaid Assets of $44.8 million for Q1 2026, up 5.58% on a YoY basis from $42.4 million in Q1 2025, and down 0.85% sequentially from $45.1 million in Q4 2025.
Vir Biotechnology (VIR) Prepaid Assets (2018 - 2026) Analysis & Trends
Vir Biotechnology (VIR) has 9 years of Prepaid Assets data on file, last reported at $44.8 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 5.58% year-over-year to $44.8 million; the trailing twelve-month figure through Mar 2026 stood at $44.8 million (up 5.58% YoY), and the FY2025 full-year result was $45.1 million, down 5.41% from the prior year.
- Prepaid Assets slipped to $44.8 million in Q1 2026, from $45.1 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $104.4 million in Q4 2022 to a low of $4.1 million in Q1 2024.
- A 5-year average of $52.8 million and a median of $45.1 million in 2025 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets slumped 95.8% in 2024 and jumped 934.0% in 2025, its largest moves.
- Tracing VIR's Prepaid Assets over 5 years: stood at $104.4 million in 2022, then slumped by 92.72% to $7.6 million in 2023, then soared by 527.96% to $47.7 million in 2024, then retreated by 5.41% to $45.1 million in 2025, then declined by 0.85% to $44.8 million in 2026.
- Business Quant data shows VIR's Prepaid Assets at $44.8 million in Q1 2026, $45.1 million in Q4 2025, and $37.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vir Biotechnology | 1.38 Bn | 1.38 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.76 Mn |
| Dec 31, 2025 | 45.14 Mn |
| Sep 30, 2025 | 36.96 Mn |
| Jun 30, 2025 | 41.47 Mn |
| Mar 31, 2025 | 42.39 Mn |
| Dec 31, 2024 | 47.73 Mn |
| Sep 30, 2024 | 43.09 Mn |
| Jun 30, 2024 | 40.73 Mn |
| Mar 31, 2024 | 4.10 Mn |
| Dec 31, 2023 | 7.60 Mn |
| Sep 30, 2023 | 59.43 Mn |
| Jun 30, 2023 | 85.74 Mn |
| Mar 31, 2023 | 97.60 Mn |
| Dec 31, 2022 | 104.36 Mn |
| Sep 30, 2022 | 54.18 Mn |
| Jun 30, 2022 | 72.42 Mn |
| Mar 31, 2022 | 69.91 Mn |
| Dec 31, 2021 | 73.00 Mn |
| Sep 30, 2021 | 27.77 Mn |
| Jun 30, 2021 | 29.23 Mn |